3
Announcements
Trials
Browse
Landscape
Status
Completed
5
Recruiting
2
Unknown
1
Terminated
1
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
444
Gynecologic
13
Genitourinary
13
Breast
11
Thoracic
9
Other
6
Sarcoma
4
Plasma cell
4
Head & Neck
4
CNS
4
Other hematologic neoplasm
2
Lymphoid
2
Endocrine
2
Dermatologic
2
Other solid neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
92
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Leukemia, Myeloid, Acute
79
Leukemia
41
Myeloproliferative Disorders
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Multiple Myeloma
21
Leukemia, Myeloid, Chronic-Phase
20
Lymphoma, Non-Hodgkin
18
Lymphoma
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Leukemia, Myelomonocytic, Chronic
16
Hodgkin Disease
14
Polycythemia Vera
13
Lymphoma, Large B-Cell, Diffuse
11
Primary Myelofibrosis
10
Neoplasms, Plasma Cell
10
Lymphoma, Follicular
10
Hematologic Neoplasms
10
Burkitt Lymphoma
10
Recurrence
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Anemia, Refractory, with Excess of Blasts
9
Myelodysplastic-Myeloproliferative Diseases
8
Mastocytosis
8
Lymphoma, Mantle-Cell
8
Lymphoma, Large-Cell, Immunoblastic
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Accelerated Phase
8
Congenital Abnormalities
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Rectal Neoplasms
×
Myeloid
×
Clear all
NCT05154474
2022-05-03
SPACE2
Weprom
Unknown
150 enrolled